Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Oncology for the Inquisitive Mind
Claim This Podcastby Michael Fernando and Josh Hurwitz
4.9(78 reviews)
226 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇬🇧
72
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality83
Social0
YouTube68
Engagement85
Podcast Overview
Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
7/31/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
72
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality83
Social0
YouTube68
Engagement85
8
Excellent Areas
2
Good Performance
9
Growth Opportunities
excellent
Publishing Consistency
Every 6 days
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Oncology for the Inquisitive Mind
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 12, 2026
208. ASCO 2026 - The Plenary Episode - Part 3
<p>This episode is the ASCO 2026 Plenary Episode. This week, all of the pivotal, game-changing, life-changing trials are discussed here. Some describe the plenary session as practice-changing, and we will always agree that better treatments with significant improvements in life expectancy and quality of life need their time in the spotlight.</p><br><p>Today, five trials are discussed, including SARC041, a liposarcoma study utilising the CDK 4/6 inhibigtor abemacicilib. Our second study is HARMONI-6, investigating whether ivonescimab plus chemotherapy is effective in patients with advanced squamous non-small cell lung cancer. Our third, almost like something written for an opera (LIBRETTO0-432), a lung cancer trial looking at selpercatinib in those with RET fusion early-stage NSCLCa. PROTEUS emerges as our fourth trial, rising from the depths of the ocean to evaluate apalutamide in the perioperative prostate cancer space.</p><br><p>Finally, and most importantly in our opinion, is RASolute302, the pancreatic cancer trial, showing that even the most difficult mutation is now treatable. An incredible story of an exceptionally difficult cancer to treat, Daraxonrasib is the star of this year's ASCO.</p><br><p><strong>Studies Discussed in this Episode</strong></p><p><strong>SARC041</strong></p><p><strong>HARMONI-6</strong></p><p><strong>LIBRETTO0-432</strong></p><p><strong>PROTEUS</strong></p><p><strong>RASolute302</strong></p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
July 5, 2026
207. ASCO 2026 - Agents of the Future - Part 2
<p>This week, Josh and Michael's ASCO 2026 coverage looks at "Agents of the Future", trials of intrigue, promise and potential beyond its status. This episode also sheds light on more orphan status cancers like head and neck cancer, basket cohort studies, resistant EGFR lung cancer, metastatic colorectal cancer and hepatocellular carcinoma.</p><br><p>One more episode left of this arc - The Plenary! Stay tuned.</p><br><p><strong>Studies Discussed in this Episode</strong></p><p>OrigAMI-4</p><p>WU-KONG28</p><p>A Phase 1/2 Study of JK06, a 5T4-Targeted Antibody Drug Conjugate (ADC), In Patients with Unresectable Locally Advanced or Metastatic Cancer</p><p>ESANOA</p><p>ROSETTA Lung-02</p><p>Ivonescimab + FOLFOX</p><p>HERIZON-CRC01</p><p>CIRCULATE</p><p>EMERALD-3</p><p>BLUESTAR</p><p>GLP-1 agonist in breast cancer (Palleschi et al)</p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
June 28, 2026
206. ASCO 2026 - Part 1
<p>ASCO 2026 is done, and Michael and Josh have created a marathon episode for you all. This week we cover "Agents of the Present", where we summarise all the important trials with updates, overall survival and progression-free survival data that could influence your practice.</p><br><p>They cover immunotherapy, lifestyle interventions, pan-PI3K inhibitors, rare cancers (such as uveal melanoma), and antibody drug conjugates, to name a few. All the cancer types are covered, including genitourinary, gynaecological cancers, breast, colorectal, lung and lifestyle interventions!</p><br><p>Two more episodes to come!</p><br><p><strong>Studies Discussed in this Episode</strong></p><p>EV-302 Extended Follow-Up</p><p>ROSELLA (Ovarian Cancer)</p><p>RAMPART (Adjuvant RCC)</p><p>VIKTORIA-1 (HR +ve Breast Cancer)</p><p>OptimUM</p><p>OPTIMA (Breast Cancer)</p><p>Anbenitimab and Chemotherapy (HER2 +ve Breast Cancer)</p><p>TALAPRO-3 (Prostate Cancer)</p><p>GLP-1 in HR +ve Breast Cancer</p><p>Lifestyle Interventions in HR +ve Breast Cancer</p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
226 total episodes available
Recent guests on Oncology for the Inquisitive Mind
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jeanne Tie
Guest
Dr Belinda Yeo
Guest
Dr James McCracken
Guest
Dr Prachi Bhave
Guest
Dr Janet Abrahm
Guest
Dr Ned McNamee
Guest
Dr Enrique Grande
Guest
Dr Anthony Joshua
Guest
Dr Adam Brufsky
Guest
Similar Podcasts
Discover related shows you might enjoy
Two Onc Docs
Sam and Karine
ASCO Daily News
American Society of Clinical Oncology (ASCO)
The Oncology Podcast
The Oncology Network
JAMA Clinical Reviews
JAMA Network
The Good GP
The Good GP
The Oncology Nursing Podcast
Oncology Nursing Society
Conversations
ABC Australia
What's That Rash?
ABC Australia
ZOE Science & Nutrition
ZOE
If You're Listening
ABC Australia
The Rest Is History
Goalhanger
The Diary Of A CEO with Steven Bartlett
DOAC
Oncology Brothers
Oncology Brothers
The Doctor's Kitchen Podcast
Dr Rupy Aujla
The Clinical Problem Solvers
The Clinical Problem Solvers
Deep-dive analytics for Oncology for the Inquisitive Mind
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Oncology for the Inquisitive Mind?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.